Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The submissions in Canada are for generic forms of semaglutide, the active ingredient in Novo Nordisk's injectable prescription drugs Ozempic and Wegovy, which have been approved by Health Canada for diabetes and weight loss respectively
Ozempic, Wegovy, and Rybelsus are all part of the same drug class and are involved in ongoing litigation regarding their potential side effects
But there are also questions worth asking before you commit
Adverse effect management : Educate patients about expected gastrointestinal effects and when to seek medical attention
Under proper supervision, a medical professional can adjust your dose, stop treatment, or give appropriate medical intervention based on your individual needs to avoid side effects
Patients typically inject 2-3 times weekly rather than daily
